Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moses S Elisaf

Showing results (161-170 of 198) with videos related to

Pageof 20
Sort By:
Biochemistry Research International|September 28, 2011
Effect of Plant Polyphenols on Adipokine Secretion from Human SGBS AdipocytesChristos S Derdemezis, Dimitrios N Kiortsis, Vasilis Tsimihodimos, et al.
Thyroid : Official Journal of the American Thyroid Association|June 14, 2003
Lipoprotein (a) levels and apolipoprotein (a) isoform size in patients with subclinical hypothyroidism: effect of treatment with levothyroxineHaralampos J Milionis, Zoe Efstathiadou, Alexandros D Tselepis, et al.
Clinical Biochemistry|September 17, 2004
Evaluation of alternative calculation methods for determining low-density lipoprotein cholesterol in hemodialysis patientsEleni T Bairaktari, Christos Tzallas, M Kalientzidou, et al.
Metabolic Syndrome and Related Disorders|November 23, 2012
Colesevelam plus rosuvastatin 5 mg/day versus rosuvastatin 10 mg/day alone on markers of insulin resistance in patients with hypercholesterolemia and impaired fasting glucoseMatilda Florentin, Evangelos N Liberopoulos, Christos V Rizos, et al.
Atherosclerosis|October 16, 2012
Effect of simvastatin or its combination with ezetimibe on Toll-like receptor expression and lipopolysaccharide - induced cytokine production in monocytes of hypercholesterolemic patientsElisavet Moutzouri, Constantinos C Tellis, Kleopatra Rousouli, et al.
Clinical Therapeutics|April 20, 2010
Effects of rosuvastatin combined with olmesartan, irbesartan, or telmisartan on indices of glucose metabolism in Greek adults with impaired fasting glucose, hypertension, and mixed hyperlipidemia: a 24-week, randomized, open-label, prospective studyChristos V Rizos, Haralampos J Milionis, Michael S Kostapanos, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 31, 2003
Hypouricemia in individuals admitted to an inpatient hospital-based facilityEleni T Bairaktari, Anna I Kakafika, Nikos Pritsivelis, et al.
Angiology|September 30, 2005
Starting with rosuvastatin in primary hyperlipidemia--Is there more than lipid lowering?Haralampos J Milionis, Irene F Gazi, Theodosios D Filippatos, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|January 4, 2008
Dose-dependent effect of rosuvastatin treatment on urinary protein excretionMichael S Kostapanos, Haralampos J Milionis, Vasilios G Saougos, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|June 12, 2010
Apolipoprotein B-to-A1 ratio as a predictor of acute ischemic nonembolic stroke in elderly subjectsMichael S Kostapanos, Leonidas G Christogiannis, Eftychia Bika, et al.
Pageof 20

Showing results (161-170 of 198) with videos related to

Sort By:
Pageof 20
Biochemistry Research International|September 28, 2011
Effect of Plant Polyphenols on Adipokine Secretion from Human SGBS AdipocytesChristos S Derdemezis, Dimitrios N Kiortsis, Vasilis Tsimihodimos, et al.
Thyroid : Official Journal of the American Thyroid Association|June 14, 2003
Lipoprotein (a) levels and apolipoprotein (a) isoform size in patients with subclinical hypothyroidism: effect of treatment with levothyroxineHaralampos J Milionis, Zoe Efstathiadou, Alexandros D Tselepis, et al.
Clinical Biochemistry|September 17, 2004
Evaluation of alternative calculation methods for determining low-density lipoprotein cholesterol in hemodialysis patientsEleni T Bairaktari, Christos Tzallas, M Kalientzidou, et al.
Metabolic Syndrome and Related Disorders|November 23, 2012
Colesevelam plus rosuvastatin 5 mg/day versus rosuvastatin 10 mg/day alone on markers of insulin resistance in patients with hypercholesterolemia and impaired fasting glucoseMatilda Florentin, Evangelos N Liberopoulos, Christos V Rizos, et al.
Atherosclerosis|October 16, 2012
Effect of simvastatin or its combination with ezetimibe on Toll-like receptor expression and lipopolysaccharide - induced cytokine production in monocytes of hypercholesterolemic patientsElisavet Moutzouri, Constantinos C Tellis, Kleopatra Rousouli, et al.
Clinical Therapeutics|April 20, 2010
Effects of rosuvastatin combined with olmesartan, irbesartan, or telmisartan on indices of glucose metabolism in Greek adults with impaired fasting glucose, hypertension, and mixed hyperlipidemia: a 24-week, randomized, open-label, prospective studyChristos V Rizos, Haralampos J Milionis, Michael S Kostapanos, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 31, 2003
Hypouricemia in individuals admitted to an inpatient hospital-based facilityEleni T Bairaktari, Anna I Kakafika, Nikos Pritsivelis, et al.
Angiology|September 30, 2005
Starting with rosuvastatin in primary hyperlipidemia--Is there more than lipid lowering?Haralampos J Milionis, Irene F Gazi, Theodosios D Filippatos, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|January 4, 2008
Dose-dependent effect of rosuvastatin treatment on urinary protein excretionMichael S Kostapanos, Haralampos J Milionis, Vasilios G Saougos, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|June 12, 2010
Apolipoprotein B-to-A1 ratio as a predictor of acute ischemic nonembolic stroke in elderly subjectsMichael S Kostapanos, Leonidas G Christogiannis, Eftychia Bika, et al.
Pageof 20